CareLit Fachartikel

Effect of Radioiodine Treatment on Quality of Life in Patients with Subclinical Hyperthyroidism: A Prospective Controlled Study

Rolf Larisch, John E. M. Midgley, Johannes W. Dietrich, Rudolf Hoermann · Nuklearmedizin - NuclearMedicine · 2024 · Heft 03 · S. 176-187

Dokument
905398
CareLit-ID
Jahr
2024
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Nuklearmedizin - NuclearMedicine
Autor:innen
Rolf Larisch, John E. M. Midgley, Johannes W. Dietrich, Rudolf Hoermann
Ausgabe
Heft 03 / 2024
Jahrgang 63
Seiten
176-187
Erschienen: 2024-06-01 00:00:00
ISSN
0029-5566

Zusammenfassung

Abstract Radioiodine treatment (RIT) has a high success rate in both the treatment of hyperthyroidism and improving the quality of life (QoL) of symptomatic patients. In asymptomatic patients with subclinical hyperthyroidism thyroid related QoL outcomes are less well known. Methods Study aim was to evaluate thyroid-related QoL in patients with subclinical hyperthyroidism mostly due to toxic nodular goitre undergoing RIT, compared to a control group of euthyroid subjects. Study design was monocentric, prospective, controlled. Fifty control subjects were enrolled and 51 RIT patients. Most subjects were examined at…

Schlagworte

subclinical hyperthyroidism quality of live radioiodine treatment prospective study Nuklearmedizin - NuclearMedicine